Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CV Sciences (CVSI) Research & Development (2016 - 2025)

CV Sciences' Research & Development history spans 13 years, with the latest figure at $24000.0 for Q3 2025.

  • For Q3 2025, Research & Development fell 17.24% year-over-year to $24000.0; the TTM value through Sep 2025 reached $129000.0, down 29.12%, while the annual FY2024 figure was $118000.0, 41.0% down from the prior year.
  • Research & Development for Q3 2025 was $24000.0 at CV Sciences, down from $50000.0 in the prior quarter.
  • Across five years, Research & Development topped out at $410000.0 in Q3 2021 and bottomed at $24000.0 in Q3 2025.
  • The 5-year median for Research & Development is $40000.0 (2023), against an average of $101157.9.
  • The largest annual shift saw Research & Development tumbled 91.29% in 2022 before it surged 169.7% in 2023.
  • A 5-year view of Research & Development shows it stood at $379000.0 in 2021, then crashed by 91.29% to $33000.0 in 2022, then soared by 169.7% to $89000.0 in 2023, then crashed by 71.91% to $25000.0 in 2024, then decreased by 4.0% to $24000.0 in 2025.
  • Per Business Quant, the three most recent readings for CVSI's Research & Development are $24000.0 (Q3 2025), $50000.0 (Q2 2025), and $30000.0 (Q1 2025).